Navigating CPNP notification for new EU markets

For a distributor, the speed and cleanliness of regulatory notification often determines how quickly a new dermocosmetic range can start generating revenue in a territory. Understanding the Cosmetic Products Notification Portal (CPNP) process — and where the responsibilities sit — is therefore a commercial priority, not just a compliance formality.

Who carries the regulatory burden

Every product placed on the EU market needs a Responsible Person (RP) established in the Union, holding the Product Information File (PIF) and ensuring compliance. As a distributor, the first thing to clarify in any partnership is how this responsibility is divided: a manufacturer that supplies complete, notification-ready documentation removes a significant cost and risk from your side.

The dossier as a launch accelerator

An incomplete PIF is the single most common cause of launch delays. Safety assessments, ingredient files, claim substantiation and stability data all need to be in order before notification. When these arrive ready-to-use from the manufacturer, the distributor can move from agreement to shelf in a fraction of the usual time.

How Galenia supports market entry

Galenia Skincare provides distribution partners with CPNP-ready dossiers, safety reports and ingredient documentation per line — designed to streamline national registration across multiple territories. For the distributor, that means lower entry cost, faster time-to-revenue and a predictable path to launch in an exclusive national market.